Depreta 30 mg and 60 mg CAPSULES

Depreta 30 mg and 60 mg CAPSULES

S5
PDF Leaflet Revision Date: 15 December 2020

API: Duloxetine | Company: Aurogen Sa

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of depression and diabetic peripheral neuropathic pain.

Dosage (summary)

60 mg once daily for adults; 30 mg once daily for mild to moderate renal impairment.

Special Populations

  • Renal impairment
  • Hepatic impairment
  • Elderly

Pregnancy & Breastfeeding

Contraindicated in pregnancy and breastfeeding.

Key Drug Interactions

  • MAOIs
  • CYP1A2 inhibitors
  • CYP2D6 inhibitors

Contraindications

  • Hypersensitivity to duloxetine
  • Severe hepatic impairment
  • Advanced renal impairment
  • Concomitant use of MAOIs
  • Children under 18 years

Common side effects

  • Nausea
  • Headache
  • Dry mouth
  • Somnolence
  • Dizziness

Counselling Points

  • Avoid abrupt discontinuation
  • Monitor for suicidal thoughts
  • Caution with alcohol and CNS depressants

Serious warnings

  • Increased risk of suicidal thoughts
  • Serotonin syndrome
  • Hypertension

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Depreta 30 mg and 60 mg CAPSULES
1/-

Connecting to Document Server

Decrypting and optimizing pharmaceutical leaflet...

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW